Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.

Saved in:
Bibliographic Details
Title: Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.
Authors: Schwarz M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine 2, Gastroenterology and Hepatology, University Hospital of St. Pölten, Karl Landsteiner University of Health Sciences, St Pölten, Austria., Hintersteininger M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Schwarz C; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine IV, Klinik Ottakring, Vienna, Austria., Panzer M; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria., Pfisterer N; Department of Internal Medicine IV, Klinik Landstraße, Vienna, Austria., Loschko N; Department of Internal Medicine 2, Johannes Kepler University Hospital Linz, Linz, Austria., Hartl L; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Dorn L; Department of Internal Medicine 2, Gastroenterology and Hepatology, University Hospital of St. Pölten, Karl Landsteiner University of Health Sciences, St Pölten, Austria., Laferl H; Department of Internal Medicine IV, Klinik Favoriten, Vienna, Austria., Trauner M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Stättermayer AF; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Mandorfer M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Graziadei I; Department of Internal Medicine, Academic Teaching Hospital Hall, Hall in Tirol, Austria., Maieron A; Department of Internal Medicine 2, Gastroenterology and Hepatology, University Hospital of St. Pölten, Karl Landsteiner University of Health Sciences, St Pölten, Austria., Moschen A; Department of Internal Medicine 2, Johannes Kepler University Hospital Linz, Linz, Austria., Aigner E; First Department of Medicine, Paracelsus Medical University, Salzburg, Austria., Stadlbauer V; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Madl C; Department of Internal Medicine IV, Klinik Landstraße, Vienna, Austria., Aberle SW; Center for Virology, Medical University of Vienna, Vienna, Austria., Zoller H; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria., Gschwantler M; Department of Internal Medicine IV, Klinik Ottakring, Vienna, Austria; Sigmund Freud University, Vienna, Austria., Reiberger T; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Electronic address: thomas.reiberger@medunwien.ac.at., Jachs M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Source: JHEP reports : innovation in hepatology [JHEP Rep] 2026 Jun; Vol. 8 (6), pp. 101835. Date of Electronic Publication: 2026 Mar 26.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101761237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-5559 (Electronic) Linking ISSN: 25895559 NLM ISO Abbreviation: JHEP Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5559
DOI:10.1016/j.jhepr.2026.101835